News

Researchers tested a gene therapy that restored partial hearing in patients with OTOF gene mutations causing congenital deafness. The therapy delivered a functional OTOF gene using an adeno-associated virus (AAV) injection.

Multimodal AI for ventricular Arrhythmia Risk Stratification (MAARS), predicts individual patients' risk for sudden cardiac death by analyzing a variety of medical data, records and contrast-enhanced MRI images of the patient's heart.

Researchers have developed a new class of nanomaterial that helps to manipulate light and improve the sensitivity of biosensors for detecting disease biomarkers.

New cutting-edge software developed in Melbourne can help uncover how the most common heart tumor in children forms and changes. The technology has the potential to further our understanding of other childhood diseases, according to a new study.

There is a perception that common drugs such as ibuprofen and SSRI preparations can trigger the intestinal disease microscopic colitis. However, a new study from Karolinska Institutet and Harvard Medical School suggests that this is not the case.

DunedinPACNI, a new tool developed by researchers from Duke University, Harvard University and the University of Otago, uses brain MRI scans to estimate a person’s pace of aging. The tool predicts future health outcomes, including dementia risk.

Researchers have developed a new alternative to mammography for breast imaging. The technique, photoacoustic computed tomography (PACT) uses a laser-sonic scanner and machine learning to identify tumors in as little as 15 seconds.

Nearly half of all patients with anxiety or depression experience no effect from the drugs they are first prescribed. Research shows that our genes may predict which drugs work, potentially allowing doctors to choose the right drug on the first try.

Researchers have developed a smart, self-powered magnetoelastic pen that can help to detect the early signs of Parkinson's disease by analyzing a person's handwriting.

Researchers discovered that women treated with unopposed estrogen hormone therapy (E-HT) were less likely to develop breast cancer than those who did not use hormone therapy.